nodes	percent_of_prediction	percent_of_DWPC	metapath
Loratadine—ABCB1—ovarian cancer	0.408	1	CbGaD
Loratadine—ABCB1—Topotecan—ovarian cancer	0.0638	0.15	CbGbCtD
Loratadine—CYP2C8—Paclitaxel—ovarian cancer	0.0467	0.11	CbGbCtD
Loratadine—ABCB1—Vinorelbine—ovarian cancer	0.045	0.106	CbGbCtD
Loratadine—CYP2D6—Vinorelbine—ovarian cancer	0.0424	0.0995	CbGbCtD
Loratadine—CYP3A4—Topotecan—ovarian cancer	0.0382	0.0898	CbGbCtD
Loratadine—CYP2C9—Paclitaxel—ovarian cancer	0.0326	0.0764	CbGbCtD
Loratadine—ABCB1—Paclitaxel—ovarian cancer	0.0316	0.0742	CbGbCtD
Loratadine—CYP3A4—Vinorelbine—ovarian cancer	0.0269	0.0633	CbGbCtD
Loratadine—ABCB1—Docetaxel—ovarian cancer	0.0228	0.0536	CbGbCtD
Loratadine—CYP3A4—Paclitaxel—ovarian cancer	0.0189	0.0444	CbGbCtD
Loratadine—ABCB1—Doxorubicin—ovarian cancer	0.017	0.04	CbGbCtD
Loratadine—CYP2D6—Doxorubicin—ovarian cancer	0.016	0.0377	CbGbCtD
Loratadine—CYP3A4—Docetaxel—ovarian cancer	0.0137	0.0321	CbGbCtD
Loratadine—CYP3A4—Doxorubicin—ovarian cancer	0.0102	0.024	CbGbCtD
Loratadine—KCNH2—myometrium—ovarian cancer	0.000628	0.0504	CbGeAlD
Loratadine—Tachycardia—Vinorelbine—ovarian cancer	0.000539	0.00352	CcSEcCtD
Loratadine—Skin disorder—Vinorelbine—ovarian cancer	0.000537	0.0035	CcSEcCtD
Loratadine—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000535	0.00349	CcSEcCtD
Loratadine—Feeling abnormal—Topotecan—ovarian cancer	0.000532	0.00347	CcSEcCtD
Loratadine—Gastrointestinal pain—Topotecan—ovarian cancer	0.000528	0.00345	CcSEcCtD
Loratadine—Asthenia—Chlorambucil—ovarian cancer	0.000521	0.0034	CcSEcCtD
Loratadine—Pharyngitis—Paclitaxel—ovarian cancer	0.000519	0.00339	CcSEcCtD
Loratadine—Hypotension—Vinorelbine—ovarian cancer	0.000516	0.00337	CcSEcCtD
Loratadine—Abdominal pain—Topotecan—ovarian cancer	0.000511	0.00333	CcSEcCtD
Loratadine—Body temperature increased—Topotecan—ovarian cancer	0.000511	0.00333	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000503	0.00329	CcSEcCtD
Loratadine—HRH1—myometrium—ovarian cancer	0.000503	0.0404	CbGeAlD
Loratadine—Diarrhoea—Chlorambucil—ovarian cancer	0.000496	0.00324	CcSEcCtD
Loratadine—Paraesthesia—Vinorelbine—ovarian cancer	0.000496	0.00324	CcSEcCtD
Loratadine—KCNH2—uterine cervix—ovarian cancer	0.000488	0.0393	CbGeAlD
Loratadine—Tinnitus—Paclitaxel—ovarian cancer	0.000488	0.00318	CcSEcCtD
Loratadine—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000477	0.00311	CcSEcCtD
Loratadine—Fatigue—Vinorelbine—ovarian cancer	0.000476	0.00311	CcSEcCtD
Loratadine—Constipation—Vinorelbine—ovarian cancer	0.000472	0.00308	CcSEcCtD
Loratadine—Pain—Vinorelbine—ovarian cancer	0.000472	0.00308	CcSEcCtD
Loratadine—Immune system disorder—Paclitaxel—ovarian cancer	0.000472	0.00308	CcSEcCtD
Loratadine—Arrhythmia—Paclitaxel—ovarian cancer	0.000467	0.00305	CcSEcCtD
Loratadine—Hepatobiliary disease—Docetaxel—ovarian cancer	0.000467	0.00305	CcSEcCtD
Loratadine—Epistaxis—Docetaxel—ovarian cancer	0.000466	0.00304	CcSEcCtD
Loratadine—Asthenia—Topotecan—ovarian cancer	0.000463	0.00302	CcSEcCtD
Loratadine—Alopecia—Paclitaxel—ovarian cancer	0.000462	0.00302	CcSEcCtD
Loratadine—Vomiting—Chlorambucil—ovarian cancer	0.000461	0.00301	CcSEcCtD
Loratadine—Increased appetite—Epirubicin—ovarian cancer	0.00046	0.003	CcSEcCtD
Loratadine—Feeling abnormal—Vinorelbine—ovarian cancer	0.000455	0.00297	CcSEcCtD
Loratadine—Asthenia—Melphalan—ovarian cancer	0.000454	0.00296	CcSEcCtD
Loratadine—Dermatitis bullous—Epirubicin—ovarian cancer	0.000452	0.00295	CcSEcCtD
Loratadine—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.000452	0.00295	CcSEcCtD
Loratadine—Tension—Paclitaxel—ovarian cancer	0.000447	0.00292	CcSEcCtD
Loratadine—Dysgeusia—Paclitaxel—ovarian cancer	0.000446	0.00291	CcSEcCtD
Loratadine—Nervousness—Paclitaxel—ovarian cancer	0.000442	0.00289	CcSEcCtD
Loratadine—Diarrhoea—Topotecan—ovarian cancer	0.000442	0.00288	CcSEcCtD
Loratadine—KCNH2—endometrium—ovarian cancer	0.000442	0.0355	CbGeAlD
Loratadine—Lethargy—Epirubicin—ovarian cancer	0.000441	0.00288	CcSEcCtD
Loratadine—Pharyngitis—Docetaxel—ovarian cancer	0.00044	0.00287	CcSEcCtD
Loratadine—Abdominal pain—Vinorelbine—ovarian cancer	0.000437	0.00285	CcSEcCtD
Loratadine—Body temperature increased—Vinorelbine—ovarian cancer	0.000437	0.00285	CcSEcCtD
Loratadine—Diarrhoea—Melphalan—ovarian cancer	0.000433	0.00282	CcSEcCtD
Loratadine—Nausea—Chlorambucil—ovarian cancer	0.000431	0.00281	CcSEcCtD
Loratadine—Dizziness—Topotecan—ovarian cancer	0.000427	0.00279	CcSEcCtD
Loratadine—Increased appetite—Doxorubicin—ovarian cancer	0.000426	0.00278	CcSEcCtD
Loratadine—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000423	0.00276	CcSEcCtD
Loratadine—Dermatitis bullous—Doxorubicin—ovarian cancer	0.000419	0.00273	CcSEcCtD
Loratadine—Agitation—Paclitaxel—ovarian cancer	0.000418	0.00273	CcSEcCtD
Loratadine—Angioedema—Paclitaxel—ovarian cancer	0.000416	0.00272	CcSEcCtD
Loratadine—Vomiting—Topotecan—ovarian cancer	0.000411	0.00268	CcSEcCtD
Loratadine—Malaise—Paclitaxel—ovarian cancer	0.000411	0.00268	CcSEcCtD
Loratadine—Syncope—Paclitaxel—ovarian cancer	0.000408	0.00266	CcSEcCtD
Loratadine—Lethargy—Doxorubicin—ovarian cancer	0.000408	0.00266	CcSEcCtD
Loratadine—Rash—Topotecan—ovarian cancer	0.000407	0.00266	CcSEcCtD
Loratadine—KCNH2—uterus—ovarian cancer	0.000407	0.0327	CbGeAlD
Loratadine—Dermatitis—Topotecan—ovarian cancer	0.000407	0.00266	CcSEcCtD
Loratadine—Headache—Topotecan—ovarian cancer	0.000405	0.00264	CcSEcCtD
Loratadine—CYP2C8—endometrium—ovarian cancer	0.000404	0.0325	CbGeAlD
Loratadine—Palpitations—Paclitaxel—ovarian cancer	0.000402	0.00263	CcSEcCtD
Loratadine—Vomiting—Melphalan—ovarian cancer	0.000402	0.00262	CcSEcCtD
Loratadine—Immune system disorder—Docetaxel—ovarian cancer	0.0004	0.00261	CcSEcCtD
Loratadine—Loss of consciousness—Paclitaxel—ovarian cancer	0.0004	0.00261	CcSEcCtD
Loratadine—Rash—Melphalan—ovarian cancer	0.000399	0.0026	CcSEcCtD
Loratadine—Dermatitis—Melphalan—ovarian cancer	0.000398	0.0026	CcSEcCtD
Loratadine—Cough—Paclitaxel—ovarian cancer	0.000397	0.00259	CcSEcCtD
Loratadine—Asthenia—Vinorelbine—ovarian cancer	0.000396	0.00259	CcSEcCtD
Loratadine—Arrhythmia—Docetaxel—ovarian cancer	0.000396	0.00258	CcSEcCtD
Loratadine—Abdominal pain upper—Epirubicin—ovarian cancer	0.000395	0.00258	CcSEcCtD
Loratadine—HRH1—epithelium—ovarian cancer	0.000395	0.0317	CbGeAlD
Loratadine—Hypertension—Paclitaxel—ovarian cancer	0.000393	0.00257	CcSEcCtD
Loratadine—Alopecia—Docetaxel—ovarian cancer	0.000392	0.00256	CcSEcCtD
Loratadine—HRH1—uterine cervix—ovarian cancer	0.000391	0.0315	CbGeAlD
Loratadine—Myalgia—Paclitaxel—ovarian cancer	0.000388	0.00253	CcSEcCtD
Loratadine—Chest pain—Paclitaxel—ovarian cancer	0.000388	0.00253	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000385	0.00251	CcSEcCtD
Loratadine—Nausea—Topotecan—ovarian cancer	0.000384	0.0025	CcSEcCtD
Loratadine—Discomfort—Paclitaxel—ovarian cancer	0.000383	0.0025	CcSEcCtD
Loratadine—Gastritis—Epirubicin—ovarian cancer	0.000383	0.0025	CcSEcCtD
Loratadine—Dry mouth—Paclitaxel—ovarian cancer	0.000379	0.00247	CcSEcCtD
Loratadine—Diarrhoea—Vinorelbine—ovarian cancer	0.000378	0.00247	CcSEcCtD
Loratadine—Dysgeusia—Docetaxel—ovarian cancer	0.000378	0.00247	CcSEcCtD
Loratadine—Nausea—Melphalan—ovarian cancer	0.000376	0.00245	CcSEcCtD
Loratadine—HRH1—decidua—ovarian cancer	0.000373	0.03	CbGeAlD
Loratadine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000372	0.00243	CcSEcCtD
Loratadine—KCNH2—female reproductive system—ovarian cancer	0.000366	0.0294	CbGeAlD
Loratadine—Shock—Paclitaxel—ovarian cancer	0.000366	0.00239	CcSEcCtD
Loratadine—Dizziness—Vinorelbine—ovarian cancer	0.000365	0.00238	CcSEcCtD
Loratadine—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000365	0.00238	CcSEcCtD
Loratadine—Nervous system disorder—Paclitaxel—ovarian cancer	0.000364	0.00238	CcSEcCtD
Loratadine—Tachycardia—Paclitaxel—ovarian cancer	0.000363	0.00237	CcSEcCtD
Loratadine—Skin disorder—Paclitaxel—ovarian cancer	0.000361	0.00236	CcSEcCtD
Loratadine—HRH1—endometrium—ovarian cancer	0.000354	0.0285	CbGeAlD
Loratadine—Gastritis—Doxorubicin—ovarian cancer	0.000354	0.00231	CcSEcCtD
Loratadine—Vomiting—Vinorelbine—ovarian cancer	0.000351	0.00229	CcSEcCtD
Loratadine—Rash—Vinorelbine—ovarian cancer	0.000348	0.00227	CcSEcCtD
Loratadine—Dermatitis—Vinorelbine—ovarian cancer	0.000348	0.00227	CcSEcCtD
Loratadine—Hypotension—Paclitaxel—ovarian cancer	0.000347	0.00227	CcSEcCtD
Loratadine—CYP2C19—vagina—ovarian cancer	0.000347	0.0279	CbGeAlD
Loratadine—Headache—Vinorelbine—ovarian cancer	0.000346	0.00226	CcSEcCtD
Loratadine—Syncope—Docetaxel—ovarian cancer	0.000346	0.00226	CcSEcCtD
Loratadine—KCNH2—bone marrow—ovarian cancer	0.000345	0.0278	CbGeAlD
Loratadine—Pollakiuria—Epirubicin—ovarian cancer	0.000345	0.00225	CcSEcCtD
Loratadine—Palpitations—Docetaxel—ovarian cancer	0.000341	0.00223	CcSEcCtD
Loratadine—Loss of consciousness—Docetaxel—ovarian cancer	0.000339	0.00221	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000339	0.00221	CcSEcCtD
Loratadine—Cough—Docetaxel—ovarian cancer	0.000337	0.0022	CcSEcCtD
Loratadine—Insomnia—Paclitaxel—ovarian cancer	0.000336	0.00219	CcSEcCtD
Loratadine—CYP2C8—female reproductive system—ovarian cancer	0.000335	0.0269	CbGeAlD
Loratadine—Paraesthesia—Paclitaxel—ovarian cancer	0.000334	0.00218	CcSEcCtD
Loratadine—Hypertension—Docetaxel—ovarian cancer	0.000333	0.00217	CcSEcCtD
Loratadine—Drowsiness—Epirubicin—ovarian cancer	0.000333	0.00217	CcSEcCtD
Loratadine—KCNH2—female gonad—ovarian cancer	0.000333	0.0268	CbGeAlD
Loratadine—KCNH2—vagina—ovarian cancer	0.000331	0.0266	CbGeAlD
Loratadine—Somnolence—Paclitaxel—ovarian cancer	0.00033	0.00216	CcSEcCtD
Loratadine—Myalgia—Docetaxel—ovarian cancer	0.000329	0.00214	CcSEcCtD
Loratadine—Chest pain—Docetaxel—ovarian cancer	0.000329	0.00214	CcSEcCtD
Loratadine—Nausea—Vinorelbine—ovarian cancer	0.000328	0.00214	CcSEcCtD
Loratadine—Dyspepsia—Paclitaxel—ovarian cancer	0.000327	0.00213	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000326	0.00213	CcSEcCtD
Loratadine—Dry mouth—Docetaxel—ovarian cancer	0.000321	0.0021	CcSEcCtD
Loratadine—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000321	0.00209	CcSEcCtD
Loratadine—Fatigue—Paclitaxel—ovarian cancer	0.00032	0.00209	CcSEcCtD
Loratadine—Pollakiuria—Doxorubicin—ovarian cancer	0.000319	0.00208	CcSEcCtD
Loratadine—Pain—Paclitaxel—ovarian cancer	0.000318	0.00207	CcSEcCtD
Loratadine—Constipation—Paclitaxel—ovarian cancer	0.000318	0.00207	CcSEcCtD
Loratadine—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000315	0.00206	CcSEcCtD
Loratadine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000315	0.00206	CcSEcCtD
Loratadine—Epistaxis—Epirubicin—ovarian cancer	0.000314	0.00205	CcSEcCtD
Loratadine—Shock—Docetaxel—ovarian cancer	0.00031	0.00202	CcSEcCtD
Loratadine—Nervous system disorder—Docetaxel—ovarian cancer	0.000309	0.00202	CcSEcCtD
Loratadine—Drowsiness—Doxorubicin—ovarian cancer	0.000308	0.00201	CcSEcCtD
Loratadine—Tachycardia—Docetaxel—ovarian cancer	0.000307	0.00201	CcSEcCtD
Loratadine—Feeling abnormal—Paclitaxel—ovarian cancer	0.000306	0.002	CcSEcCtD
Loratadine—Skin disorder—Docetaxel—ovarian cancer	0.000306	0.002	CcSEcCtD
Loratadine—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000304	0.00198	CcSEcCtD
Loratadine—CYP2C8—vagina—ovarian cancer	0.000303	0.0243	CbGeAlD
Loratadine—CYP2C9—female reproductive system—ovarian cancer	0.000297	0.0239	CbGeAlD
Loratadine—Pharyngitis—Epirubicin—ovarian cancer	0.000297	0.00194	CcSEcCtD
Loratadine—KCNH2—testis—ovarian cancer	0.000295	0.0237	CbGeAlD
Loratadine—Hypotension—Docetaxel—ovarian cancer	0.000294	0.00192	CcSEcCtD
Loratadine—Body temperature increased—Paclitaxel—ovarian cancer	0.000294	0.00192	CcSEcCtD
Loratadine—Abdominal pain—Paclitaxel—ovarian cancer	0.000294	0.00192	CcSEcCtD
Loratadine—HRH1—female reproductive system—ovarian cancer	0.000293	0.0236	CbGeAlD
Loratadine—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000292	0.0019	CcSEcCtD
Loratadine—Epistaxis—Doxorubicin—ovarian cancer	0.000291	0.0019	CcSEcCtD
Loratadine—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000287	0.00187	CcSEcCtD
Loratadine—Insomnia—Docetaxel—ovarian cancer	0.000285	0.00186	CcSEcCtD
Loratadine—Paraesthesia—Docetaxel—ovarian cancer	0.000283	0.00185	CcSEcCtD
Loratadine—Somnolence—Docetaxel—ovarian cancer	0.00028	0.00183	CcSEcCtD
Loratadine—Tinnitus—Epirubicin—ovarian cancer	0.000279	0.00182	CcSEcCtD
Loratadine—Dyspepsia—Docetaxel—ovarian cancer	0.000277	0.00181	CcSEcCtD
Loratadine—ABCB1—myometrium—ovarian cancer	0.000275	0.0221	CbGeAlD
Loratadine—Pharyngitis—Doxorubicin—ovarian cancer	0.000275	0.00179	CcSEcCtD
Loratadine—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000272	0.00177	CcSEcCtD
Loratadine—Fatigue—Docetaxel—ovarian cancer	0.000272	0.00177	CcSEcCtD
Loratadine—CYP2C8—testis—ovarian cancer	0.00027	0.0217	CbGeAlD
Loratadine—Immune system disorder—Epirubicin—ovarian cancer	0.00027	0.00176	CcSEcCtD
Loratadine—Pain—Docetaxel—ovarian cancer	0.000269	0.00176	CcSEcCtD
Loratadine—Constipation—Docetaxel—ovarian cancer	0.000269	0.00176	CcSEcCtD
Loratadine—Arrhythmia—Epirubicin—ovarian cancer	0.000267	0.00174	CcSEcCtD
Loratadine—HRH1—female gonad—ovarian cancer	0.000267	0.0215	CbGeAlD
Loratadine—Asthenia—Paclitaxel—ovarian cancer	0.000267	0.00174	CcSEcCtD
Loratadine—HRH1—vagina—ovarian cancer	0.000265	0.0213	CbGeAlD
Loratadine—ABCB1—embryo—ovarian cancer	0.000265	0.0213	CbGeAlD
Loratadine—Alopecia—Epirubicin—ovarian cancer	0.000264	0.00172	CcSEcCtD
Loratadine—Feeling abnormal—Docetaxel—ovarian cancer	0.00026	0.00169	CcSEcCtD
Loratadine—Tinnitus—Doxorubicin—ovarian cancer	0.000258	0.00168	CcSEcCtD
Loratadine—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000258	0.00168	CcSEcCtD
Loratadine—Tension—Epirubicin—ovarian cancer	0.000255	0.00167	CcSEcCtD
Loratadine—Dysgeusia—Epirubicin—ovarian cancer	0.000255	0.00166	CcSEcCtD
Loratadine—Diarrhoea—Paclitaxel—ovarian cancer	0.000254	0.00166	CcSEcCtD
Loratadine—Nervousness—Epirubicin—ovarian cancer	0.000253	0.00165	CcSEcCtD
Loratadine—Immune system disorder—Doxorubicin—ovarian cancer	0.00025	0.00163	CcSEcCtD
Loratadine—Abdominal pain—Docetaxel—ovarian cancer	0.000249	0.00163	CcSEcCtD
Loratadine—Body temperature increased—Docetaxel—ovarian cancer	0.000249	0.00163	CcSEcCtD
Loratadine—Arrhythmia—Doxorubicin—ovarian cancer	0.000247	0.00161	CcSEcCtD
Loratadine—Dizziness—Paclitaxel—ovarian cancer	0.000246	0.0016	CcSEcCtD
Loratadine—Desloratadine—ABCB1—ovarian cancer	0.000245	1	CrCbGaD
Loratadine—Alopecia—Doxorubicin—ovarian cancer	0.000245	0.0016	CcSEcCtD
Loratadine—Ill-defined disorder—Epirubicin—ovarian cancer	0.000242	0.00158	CcSEcCtD
Loratadine—Agitation—Epirubicin—ovarian cancer	0.000239	0.00156	CcSEcCtD
Loratadine—HRH1—testis—ovarian cancer	0.000237	0.019	CbGeAlD
Loratadine—Tension—Doxorubicin—ovarian cancer	0.000236	0.00154	CcSEcCtD
Loratadine—Vomiting—Paclitaxel—ovarian cancer	0.000236	0.00154	CcSEcCtD
Loratadine—Dysgeusia—Doxorubicin—ovarian cancer	0.000236	0.00154	CcSEcCtD
Loratadine—Malaise—Epirubicin—ovarian cancer	0.000235	0.00153	CcSEcCtD
Loratadine—Rash—Paclitaxel—ovarian cancer	0.000234	0.00153	CcSEcCtD
Loratadine—Dermatitis—Paclitaxel—ovarian cancer	0.000234	0.00153	CcSEcCtD
Loratadine—Nervousness—Doxorubicin—ovarian cancer	0.000234	0.00153	CcSEcCtD
Loratadine—Syncope—Epirubicin—ovarian cancer	0.000233	0.00152	CcSEcCtD
Loratadine—Headache—Paclitaxel—ovarian cancer	0.000233	0.00152	CcSEcCtD
Loratadine—Palpitations—Epirubicin—ovarian cancer	0.00023	0.0015	CcSEcCtD
Loratadine—Loss of consciousness—Epirubicin—ovarian cancer	0.000229	0.00149	CcSEcCtD
Loratadine—Cough—Epirubicin—ovarian cancer	0.000227	0.00148	CcSEcCtD
Loratadine—CYP3A4—female reproductive system—ovarian cancer	0.000227	0.0182	CbGeAlD
Loratadine—Asthenia—Docetaxel—ovarian cancer	0.000226	0.00147	CcSEcCtD
Loratadine—Hypertension—Epirubicin—ovarian cancer	0.000225	0.00147	CcSEcCtD
Loratadine—Ill-defined disorder—Doxorubicin—ovarian cancer	0.000223	0.00146	CcSEcCtD
Loratadine—CYP2D6—female reproductive system—ovarian cancer	0.000223	0.0179	CbGeAlD
Loratadine—Myalgia—Epirubicin—ovarian cancer	0.000222	0.00145	CcSEcCtD
Loratadine—Chest pain—Epirubicin—ovarian cancer	0.000222	0.00145	CcSEcCtD
Loratadine—Agitation—Doxorubicin—ovarian cancer	0.000221	0.00144	CcSEcCtD
Loratadine—Nausea—Paclitaxel—ovarian cancer	0.000221	0.00144	CcSEcCtD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.00022	0.00144	CcSEcCtD
Loratadine—Discomfort—Epirubicin—ovarian cancer	0.000219	0.00143	CcSEcCtD
Loratadine—Malaise—Doxorubicin—ovarian cancer	0.000217	0.00142	CcSEcCtD
Loratadine—Dry mouth—Epirubicin—ovarian cancer	0.000217	0.00141	CcSEcCtD
Loratadine—ABCB1—epithelium—ovarian cancer	0.000216	0.0174	CbGeAlD
Loratadine—Syncope—Doxorubicin—ovarian cancer	0.000216	0.00141	CcSEcCtD
Loratadine—Diarrhoea—Docetaxel—ovarian cancer	0.000216	0.00141	CcSEcCtD
Loratadine—ABCB1—uterine cervix—ovarian cancer	0.000214	0.0172	CbGeAlD
Loratadine—KCNH2—lymph node—ovarian cancer	0.000214	0.0172	CbGeAlD
Loratadine—Palpitations—Doxorubicin—ovarian cancer	0.000213	0.00139	CcSEcCtD
Loratadine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000212	0.00139	CcSEcCtD
Loratadine—Loss of consciousness—Doxorubicin—ovarian cancer	0.000212	0.00138	CcSEcCtD
Loratadine—Cough—Doxorubicin—ovarian cancer	0.00021	0.00137	CcSEcCtD
Loratadine—Shock—Epirubicin—ovarian cancer	0.000209	0.00136	CcSEcCtD
Loratadine—Nervous system disorder—Epirubicin—ovarian cancer	0.000208	0.00136	CcSEcCtD
Loratadine—Dizziness—Docetaxel—ovarian cancer	0.000208	0.00136	CcSEcCtD
Loratadine—Hypertension—Doxorubicin—ovarian cancer	0.000208	0.00136	CcSEcCtD
Loratadine—Tachycardia—Epirubicin—ovarian cancer	0.000207	0.00135	CcSEcCtD
Loratadine—Skin disorder—Epirubicin—ovarian cancer	0.000206	0.00135	CcSEcCtD
Loratadine—Myalgia—Doxorubicin—ovarian cancer	0.000205	0.00134	CcSEcCtD
Loratadine—Chest pain—Doxorubicin—ovarian cancer	0.000205	0.00134	CcSEcCtD
Loratadine—ABCB1—decidua—ovarian cancer	0.000204	0.0164	CbGeAlD
Loratadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000204	0.00133	CcSEcCtD
Loratadine—CYP2D6—female gonad—ovarian cancer	0.000203	0.0163	CbGeAlD
Loratadine—Discomfort—Doxorubicin—ovarian cancer	0.000203	0.00132	CcSEcCtD
Loratadine—Dry mouth—Doxorubicin—ovarian cancer	0.000201	0.00131	CcSEcCtD
Loratadine—Vomiting—Docetaxel—ovarian cancer	0.0002	0.00131	CcSEcCtD
Loratadine—Rash—Docetaxel—ovarian cancer	0.000199	0.0013	CcSEcCtD
Loratadine—Hypotension—Epirubicin—ovarian cancer	0.000199	0.0013	CcSEcCtD
Loratadine—Dermatitis—Docetaxel—ovarian cancer	0.000198	0.00129	CcSEcCtD
Loratadine—Headache—Docetaxel—ovarian cancer	0.000197	0.00129	CcSEcCtD
Loratadine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000197	0.00128	CcSEcCtD
Loratadine—ABCB1—endometrium—ovarian cancer	0.000194	0.0156	CbGeAlD
Loratadine—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000194	0.00126	CcSEcCtD
Loratadine—Shock—Doxorubicin—ovarian cancer	0.000193	0.00126	CcSEcCtD
Loratadine—Nervous system disorder—Doxorubicin—ovarian cancer	0.000193	0.00126	CcSEcCtD
Loratadine—Insomnia—Epirubicin—ovarian cancer	0.000192	0.00125	CcSEcCtD
Loratadine—Tachycardia—Doxorubicin—ovarian cancer	0.000192	0.00125	CcSEcCtD
Loratadine—Skin disorder—Doxorubicin—ovarian cancer	0.000191	0.00125	CcSEcCtD
Loratadine—Paraesthesia—Epirubicin—ovarian cancer	0.000191	0.00125	CcSEcCtD
Loratadine—Somnolence—Epirubicin—ovarian cancer	0.000189	0.00123	CcSEcCtD
Loratadine—Nausea—Docetaxel—ovarian cancer	0.000187	0.00122	CcSEcCtD
Loratadine—Dyspepsia—Epirubicin—ovarian cancer	0.000187	0.00122	CcSEcCtD
Loratadine—Hypotension—Doxorubicin—ovarian cancer	0.000184	0.0012	CcSEcCtD
Loratadine—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000183	0.0012	CcSEcCtD
Loratadine—Fatigue—Epirubicin—ovarian cancer	0.000183	0.0012	CcSEcCtD
Loratadine—Pain—Epirubicin—ovarian cancer	0.000182	0.00119	CcSEcCtD
Loratadine—Constipation—Epirubicin—ovarian cancer	0.000182	0.00119	CcSEcCtD
Loratadine—CYP2D6—testis—ovarian cancer	0.00018	0.0145	CbGeAlD
Loratadine—ABCB1—gonad—ovarian cancer	0.00018	0.0144	CbGeAlD
Loratadine—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000179	0.00117	CcSEcCtD
Loratadine—ABCB1—uterus—ovarian cancer	0.000179	0.0144	CbGeAlD
Loratadine—Insomnia—Doxorubicin—ovarian cancer	0.000178	0.00116	CcSEcCtD
Loratadine—Paraesthesia—Doxorubicin—ovarian cancer	0.000177	0.00115	CcSEcCtD
Loratadine—Feeling abnormal—Epirubicin—ovarian cancer	0.000175	0.00114	CcSEcCtD
Loratadine—Somnolence—Doxorubicin—ovarian cancer	0.000175	0.00114	CcSEcCtD
Loratadine—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000174	0.00113	CcSEcCtD
Loratadine—Dyspepsia—Doxorubicin—ovarian cancer	0.000173	0.00113	CcSEcCtD
Loratadine—HRH1—lymph node—ovarian cancer	0.000172	0.0138	CbGeAlD
Loratadine—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.00017	0.00111	CcSEcCtD
Loratadine—Fatigue—Doxorubicin—ovarian cancer	0.000169	0.00111	CcSEcCtD
Loratadine—Constipation—Doxorubicin—ovarian cancer	0.000168	0.0011	CcSEcCtD
Loratadine—Pain—Doxorubicin—ovarian cancer	0.000168	0.0011	CcSEcCtD
Loratadine—Abdominal pain—Epirubicin—ovarian cancer	0.000168	0.0011	CcSEcCtD
Loratadine—Body temperature increased—Epirubicin—ovarian cancer	0.000168	0.0011	CcSEcCtD
Loratadine—Feeling abnormal—Doxorubicin—ovarian cancer	0.000162	0.00106	CcSEcCtD
Loratadine—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000161	0.00105	CcSEcCtD
Loratadine—ABCB1—female reproductive system—ovarian cancer	0.000161	0.0129	CbGeAlD
Loratadine—Body temperature increased—Doxorubicin—ovarian cancer	0.000155	0.00101	CcSEcCtD
Loratadine—Abdominal pain—Doxorubicin—ovarian cancer	0.000155	0.00101	CcSEcCtD
Loratadine—Asthenia—Epirubicin—ovarian cancer	0.000152	0.000995	CcSEcCtD
Loratadine—ABCB1—bone marrow—ovarian cancer	0.000152	0.0122	CbGeAlD
Loratadine—ABCB1—female gonad—ovarian cancer	0.000146	0.0117	CbGeAlD
Loratadine—Diarrhoea—Epirubicin—ovarian cancer	0.000145	0.000949	CcSEcCtD
Loratadine—ABCB1—vagina—ovarian cancer	0.000145	0.0117	CbGeAlD
Loratadine—Asthenia—Doxorubicin—ovarian cancer	0.000141	0.00092	CcSEcCtD
Loratadine—Dizziness—Epirubicin—ovarian cancer	0.00014	0.000917	CcSEcCtD
Loratadine—Vomiting—Epirubicin—ovarian cancer	0.000135	0.000882	CcSEcCtD
Loratadine—Diarrhoea—Doxorubicin—ovarian cancer	0.000135	0.000878	CcSEcCtD
Loratadine—Rash—Epirubicin—ovarian cancer	0.000134	0.000874	CcSEcCtD
Loratadine—Dermatitis—Epirubicin—ovarian cancer	0.000134	0.000873	CcSEcCtD
Loratadine—Headache—Epirubicin—ovarian cancer	0.000133	0.000869	CcSEcCtD
Loratadine—Dizziness—Doxorubicin—ovarian cancer	0.00013	0.000848	CcSEcCtD
Loratadine—ABCB1—testis—ovarian cancer	0.00013	0.0104	CbGeAlD
Loratadine—Nausea—Epirubicin—ovarian cancer	0.000126	0.000824	CcSEcCtD
Loratadine—Vomiting—Doxorubicin—ovarian cancer	0.000125	0.000816	CcSEcCtD
Loratadine—Rash—Doxorubicin—ovarian cancer	0.000124	0.000809	CcSEcCtD
Loratadine—Dermatitis—Doxorubicin—ovarian cancer	0.000124	0.000808	CcSEcCtD
Loratadine—Headache—Doxorubicin—ovarian cancer	0.000123	0.000804	CcSEcCtD
Loratadine—Nausea—Doxorubicin—ovarian cancer	0.000117	0.000762	CcSEcCtD
Loratadine—ABCB1—lymph node—ovarian cancer	9.39e-05	0.00755	CbGeAlD
